Raven Biotechnologies News
Most Popular Raven Biotechnologies Story
VaxGen faces possible liquidation after merger flops
The spectacularly unsuccessful VaxGen has called off an effort to Read more...
Latest Headlines
- VaxGen faces possible liquidation after merger flopsApril 3, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
More Research Reports >>
